- 充值
- 会员
- 职称材料
文献信息
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions. The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.
Inhibitor TreatmentHydrochlorideII Clinical TrialsReceptor AntagonistGastrointestinal DisordersPhase III Clinical TrialsU.S. Food and Drug AdministrationDrug DiscoveryNon-Small Cell Lung CancerMonoclonal Antibody Treatmentin Vitro and in VivoCognition EnhancerTherapeutic TargetsReceptor AntagonistsAmerican SocietyClinical DevelopmentMonoclonal AntibodyQualified Infectious Disease ProductReceptor AgonistAntagonist Treatment
vol.48 (2023)
vol.47 (2022)
vol.46 (2021)
vol.45 (2021)
vol.45 (2020)
vol.44 (2019)
vol.4 (2019)
vol.43 (2018)
vol.42 (2017)
vol.41 (2016)
vol.40 (2015)
vol.39 (2014)
vol.38 (2013)
vol.37 (2012)
vol.36 (2011)
vol.35 (2010)
vol.34 (2009)
vol.33 (2008)
vol.32 (2007)
vol.31 (2006)
vol.30 (2005)
vol.29 (2004)
vol.28 (2003)
vol.27 (2002)
vol.26 (2001)
vol.25 (2000)
vol.24 (1999)
vol.23 (1998)
vol.22 (1997)
vol.21 (1996)
vol.20 (1995)
vol.19 (1994)
vol.18 (1993)
vol.17 (1992)
vol.16 (1991)
vol.15 (1990)
vol.14 (1989)
vol.13 (1988)
vol.12 (1987)
vol.11 (1986)
vol.10 (1985)
vol.9 (1984)
vol.8 (1983)
vol.7 (1982)
vol.6 (1981)
vol.5 (1980)
vol.4 (1979)
vol.3 (1978)